( NASDAQ-NMS:ENDP, Toronto:ENDP )

News from Endo International plc A wide array of domestic and global news stories on topics including politics, business, technology, religion, sports, entertainment, science, health and lifestyle.

Latest News from Endo International plc

15 Aug, 2018, 11:00 BST Endo Lifts Temporary Stay of FDA Litigation Following the Launch of a Bulk-Compounded Vasopressin Product by a Section 503B Outsourcing Facility

Endo International plc (NASDAQ: ENDP) today announced that it is lifting a temporary stay of its litigation against the U.S. Food and Drug...


09 Aug, 2018, 12:30 BST PGA Golfer Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Parents to Get Their Own Check-Ups This Back-to-School Season

PGA golfer Tim Herron is working with Facts on Hand to put a spotlight on Dupuytren's Contracture, a hand condition that generally appears after...


08 Aug, 2018, 12:00 BST Endo Reports Second-Quarter 2018 Financial Results

- Second-quarter 2018 revenues of $715 million compared to second-quarter 2017 revenues of $876 million - Second-quarter 2018...


02 Aug, 2018, 12:30 BST Endo Announces Appointment of Laure Park as Senior Vice President, Investor Relations and Corporate Affairs

Endo International plc (NASDAQ: ENDP) announced today that it has appointed Laure Park as Senior Vice President, Investor Relations and Corporate...


27 Jul, 2018, 12:30 BST Endo Begins Shipment of Authorized Generic Version of INVANZ® (ertapenem for injection) in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an...


25 Jul, 2018, 12:30 BST Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada

Endo International plc (NASDAQ: ENDP), announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with...


20 Jul, 2018, 12:30 BST Endo to Announce Second-Quarter 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2018 financial results on August 8, 2018 and members of its senior...


02 Jul, 2018, 12:30 BST Endo Begins Shipment of Authorized Generic Version of Colcrys® (colchicine, USP) in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping an...


11 Jun, 2018, 20:37 BST Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC...


08 May, 2018, 11:30 BST Endo Reports First-Quarter 2018 Financial Results

- First-quarter 2018 revenues of $701 million - First-quarter 2018 Branded Specialty Products revenues increased 7 percent versus...


02 May, 2018, 12:30 BST Endo to Participate at the UBS Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the UBS...


27 Apr, 2018, 12:30 BST Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Featured During The Hot Topics Symposium At The Aesthetic Meeting 2018

Endo International plc (NASDAQ: ENDP) today announced the presentation of clinical data from a Phase 2b investigational study of collagenase...


26 Apr, 2018, 13:32 BST Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited

Endo International plc (NASDAQ: ENDP) today announced that it has reached definitive agreements to acquire Somerset Therapeutics, LLC, a New Jersey...


17 Apr, 2018, 21:48 BST Endo Receives Paragraph IV Notification on Vasostrict®

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, have received...


13 Apr, 2018, 12:30 BST Endo to Announce First-Quarter 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2018 financial results on May 8, 2018 and members of its senior management...


02 Apr, 2018, 12:30 BST Endo Agrees to Extend Temporary Stay of FDA Litigation

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to extend a temporary stay of its litigation against the U.S. Food and...


01 Mar, 2018, 23:46 GMT Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC (Par),...


27 Feb, 2018, 11:00 GMT Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results

- Fourth-quarter 2017 revenues of $769 million; Full-year 2017 revenues of $3,469 million - Fourth-quarter 2017 Sterile...


06 Feb, 2018, 12:30 GMT Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite

Endo International plc (NASDAQ: ENDP) today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium...


29 Jan, 2018, 12:30 GMT Endo to Announce Fourth-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter 2017 financial results on February 27, 2018 and members of its senior...


24 Jan, 2018, 22:14 GMT Endo Agrees to FDA's Request to Seek Temporary Litigation Stay

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to a request by the U.S. Food and Drug Administration (FDA) to seek a...


11 Jan, 2018, 13:30 GMT Endo Comments on United States Attorney's Office Grand Jury Subpoena Relating to Products Containing Oxymorphone

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that its subsidiary, Endo Pharmaceuticals Inc. ("EPI"), has received a grand jury...


28 Dec, 2017, 13:30 GMT Endo to Participate at the 36th Annual J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the 36th...


17 Nov, 2017, 21:01 GMT Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that Blaise Coleman, Executive Vice President and Chief Financial Officer, will participate...


09 Nov, 2017, 21:01 GMT Endo Reports Third-Quarter 2017 Financial Results

- Third-quarter 2017 revenues of $787 million and reported $0.45 diluted (GAAP) loss per share from continuing operations -...